智通财经APP获悉，香港联交所最新数据显示，11月13日，OrbiMed Advisors V Limited增持微泰医疗-B(02235)90万股，每股作价6.04港元，总金额约为543.6万港元。增持后最新持股数目约为2067.01万股，持股比例为12.22%。
本交易涉及关联方：OrbiMed Asia GP V, L.P.、OrbiMed Asia Partners V. L.P.。
智通财经APP获悉，香港联交所最新数据显示，11月13日，OrbiMed Advisors V Limited增持微泰医疗-B(02235)90万股，每股作价6.04港元，总金额约为543.6万港元。增持后最新持股数目约为2067.01万股，持股比例为12.22%。
本交易涉及关联方：OrbiMed Asia GP V, L.P.、OrbiMed Asia Partners V. L.P.。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.